Paradoxical modulation of influenza by intranasal administration of non-replicating adenovirus particles

De-Chu Christopher Tang1

  • 1VaxDome Inc., Commercialization Program, University of North Texas Health Science Center, Fort Worth, Texas, United States of America.

Plos One
|November 12, 2020
PubMed

Insights

Intranasal adenovirus particles can protect against or worsen influenza virus infection in mice. The outcome depends on timing, mouse strain, and adenovirus boosts, highlighting the complex role of innate immunity.

Area of Science:

  • Immunology
  • Virology
  • Infectious Diseases

Background:

  • Respiratory mucosal infections by airborne microbes are frequent.
  • Adenovirus (Ad) particles administered intranasally can influence influenza virus (IFV) infection outcomes.
  • The interaction between Ad and host innate immunity is critical in determining protection or exacerbation.

Purpose of the Study:

  • To investigate the dual role of intranasal non-replicating adenovirus particles in influenza virus infection.
  • To determine how the timing of Ad administration and specific host factors influence IFV challenge outcomes.
  • To explore the potential for synergistic effects of Ad administration and vaccination in mitigating influenza.

Main Methods:

  • Intranasal administration of non-replicating adenovirus particles to different mouse strains (Balb/c, C57BL/6).
  • Challenge with influenza virus at various time points before and after Ad administration.
  • Evaluation of protection or exacerbation of IFV infection, including survival rates.

Main Results:

  • Intranasal Ad administration 1-47 days prior to IFV challenge conferred rapid protection in Balb/c mice.
  • Ad exposure 39 days before or 1 day after IFV challenge induced rapid death in C57BL/6 mice.
  • Consecutive Ad administrations demonstrated synergy, reversing detrimental effects and enhancing protection.

Conclusions:

  • The outcome of IFV infection following Ad administration is highly dependent on the timing of exposure, mouse strain, and Ad boost strategy.
  • Adenovirus particles can modulate innate immunity to either protect against or exacerbate IFV infection.
  • Further research is needed to fully characterize the mechanisms underlying these differential effects and their potential clinical applications.